Search

everythinglearnresearchcommunity

for

Search:↓

Deleting the EDAR gene in Cashmere goats affects genes and proteins related to hair growth.

Proper management of the dilation program is crucial after male-to-female reassignment surgery.

TGF-β and FGF pathways are crucial for skin development and regeneration.

A rare EGFR mutation in newborns leads to severe health issues and early death.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

PRP derivatives are likely safe for therapeutic use without harmful effects.

Two growth factors, PDGF and FGF2, can potentially be used together to grow enough cells for a hair loss treatment, but their exact function on human cells needs further confirmation.

The enzyme Dgat1 is essential for healthy hair and skin by controlling retinoid levels.

Dermoscopy is a useful tool for diagnosing and managing topical steroid dependent face.

The new drug delivery system improves exemestane's absorption and effectiveness.

Mutations in Gasdermin A3 cause skin inflammation and hair loss by disrupting mitochondria.

EREG therapy may help treat hair loss by promoting hair growth.

A new mouse model helps study melanocyte cells using GFP expression.

bFGF delays hair growth in mice.

Three new finasteride solvates found, change forms under different drying conditions.

Gefitinib can cause hair loss without scarring.

Hair glycation can indicate long-term blood sugar levels and diabetic nerve issues.

Green tea compound EGCG may help hair growth by boosting cell activity.

Sheep cells were successfully modified to include a spider silk protein gene.

Entospletinib effectively prevents eye and skin GVHD in mice.

Familial dyskeratotic comedones are a rare, benign skin disorder that is hard to treat.

cgVEGF164 boosts hair follicle growth in mice.

Finasteride changes antioxidant enzyme expression, possibly affecting sperm protection in rats.

Heat-killed Enterococcus faecalis EF-2001 may promote hair growth and transition hair follicles to the growth phase.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.